MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2

Biological research: BR

Feng Xing¹ 

[1] Department of Obstetrics and Gynecology, Shanghai Tenth Peoples Hospital of Tongji University, Tongji University School of Medicine, Shanghai, China

关键词: Ovarian cancer;    miR-219-5p;    HMGA2;    Growth;    Metastasis;   

DOI  :  10.1186/s40659-018-0199-y

学科分类：生物科学（综合）

来源: BioMed Central

【 摘 要 】

Accumulating studies have demonstrated that high-mobility group A2 (HMGA2), an oncofetal protein, plays a role in tumor development and progression. However, the molecular role of HMGA2 in ovarian carcinoma is yet to be established. MicroRNAs (miRNAs), a group of small noncoding RNAs, negatively regulate gene expression and their dysregulation has been implicated in tumorigenesis. The aim of this study was to investigate the potential involvement of a specific miRNA, miR-219-5p, in HMGA2-induced ovarian cancer. The ovarian cancer cell line, SKOV3, was employed, and miR-219-5p and HMGA2 overexpression vectors constructed. The CCK-8 kit was used to determine cell proliferation and the Transwell® assay used to measure cell invasion and migration. RT-PCR and western blot analyses were applied to analyze the expression of miR-219-5p and HMGA2, and the luciferase reporter assay used to examine the interactions between miR-219-5p and HMGA2. Nude mice were employed to characterize in vivo tumor growth regulation. Expression of miR-219-5p led to suppression of proliferation, invasion and migration of the ovarian cancer cell line, SKOV3, by targeting HMGA2. The inhibitory effects of miR-219-5p were reversed upon overexpression of HMGA2. Data from the luciferase reporter assay showed that miR-219-5p downregulates HMGA2 via direct integration with its 3′-UTR. Consistent with in vitro findings, expression of miR-219-5p led to significant inhibition of tumor growth in vivo. Our results collectively suggest that miR-219-5p inhibits tumor growth and metastasis by targeting HMGA2.

【 授权许可】

CC BY